<DOC>
	<DOCNO>NCT01410981</DOCNO>
	<brief_summary>The purpose study understand small protein find surface myeloma cell ( call CXCR4 CD47 ) inside myeloma cell ( Pim kinases , sphingolipids , pS6 ) predict patient respond chemotherapy-treatment small molecule inside myeloma cell ( call Pim kinase ) use treatment target myeloma . A sample bone marrow biopsy ( small amount tissue remove body laboratory test ) aspirate ( small amount fluid remove body laboratory test ) do subject enter study provide research purpose . Based preliminary data , hypothesize CXCR4 , CD47 , sphingolipids , Pim kinase could use prognostic/predictive marker Pim kinase inhibitor provide new agent treatment multiple myeloma .</brief_summary>
	<brief_title>Prognostic Potential Cell Surface Markers Pim Kinases Multiple Myeloma</brief_title>
	<detailed_description />
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<criteria>A diagnosis multiple myeloma possible multiple myeloma bone marrow biopsy aspirate Planned therapy standard chemotreatment multiple myeloma Laboratory data calcium , beta 2microglobulin , albumin , creatinine bone survey available stag purpose . â‰¥18 year old &lt; 18 year old Patients receive chemotreatment Patients whose treatment record available</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
</DOC>